Vaxcyte Jumps on Phase 3 Vaccine Win as Biotech Stocks Set Records
Vaxcyte shares shot up 31 percent after strong Phase 3 results for its pneumococcal vaccine. The news sparked a rally, sending several biotech stocks to fresh 52-week highs.
Clinical Trial Statistics 1 article
Quantitative inference from human studies defines Clinical Trial Statistics, from treatment-effect estimation and confidence intervals to survival analysis, multiplicity, missing data and interim looks. The section asks how uncertainty is measured and how statistical choices shape interpretation of a clinical result. It is separate from Trial Design, which determines study architecture, and from Clinical Endpoints, which concerns what is measured rather than how observed outcomes are analyzed.